Neuca S.A. (NEU)
GPW
Closed
Oct 7, 2026
Day's Range
710.0052 wk Range
627.00Overview - NEU - Neuca S.A.
Key Statistics
Valuation
Enterprise Value
4.14B
P/E (Trailing)
‪16.53‬
P/E (Forward)
‪12.90‬
PEG Ratio
‪0.15‬
Price / Sales (TTM)
‪0.22‬
Price / Book
‪2.85‬
EV / EBITDA
‪11.27‬
Profitability
Gross Margin
‪11.81%‬
Profit Margin
‪1.39%‬
Operating Margin
‪1.84%‬
Return on Assets
‪3.02%‬
Return on Equity
‪14.97%‬
Ownership
Shares Outstanding
4.51M
Float
1.61M
Held by Insiders
‪60.55%‬
Held by Institutions
‪9.93%‬
Price stats
Beta
‪0.46‬
50-Day Avg
‪757.40‬
200-Day Avg
‪747.37‬
Dividends
Payout Ratio
‪79.10%‬
Frequency
Annual
Analyst Consensus
5 analysts
Average price target
‪PLN 922.64‬Market Cap - NEU - Neuca S.A.
Peers - NEU - Neuca S.A.
Peer Comparison
Compared with companies in Medical Distribution listed on GPW.
- NEUGPWNeuca S.A.3.19BMarket Cap+4.82%52-week change16.53P/E (Trailing)‪1.39%‬Profit Margin
- SPHGPWSopharma AD5.76BMarket Cap-19.16%52-week change31.15P/E (Trailing)‪5.85%‬Profit Margin
- NVGGPWNovavis Group S.A.21.42MMarket Cap-106.86%52-week change172.00P/E (Trailing)‪204.81%‬Profit Margin
Profile Summary - NEU - Neuca S.A.
About
Neuca S.A. is a leading healthcare company, primarily focused on the wholesale distribution of pharmaceuticals across Poland. The company's primary function is to ensure the efficient supply of pharmaceutical products to pharmacies, hospitals, and healthcare institutions, thereby playing a crucial role in the…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
